RHUMBLINE ADVISERS - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 86 filers reported holding DESIGN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$123,835
-61.9%
52,476
+1.7%
0.00%
Q2 2023$325,017
+108966.1%
51,590
-0.2%
0.00%
Q1 2023$298
-43.8%
51,688
+0.1%
0.00%
-100.0%
Q4 2022$530
-99.9%
51,616
-0.3%
0.00%0.0%
Q3 2022$866,000
+28.3%
51,772
+7.3%
0.00%0.0%
Q2 2022$675,000
+47.7%
48,228
+70.5%
0.00%0.0%
Q1 2022$457,000
-8.4%
28,284
+21.4%
0.00%0.0%
Q4 2021$499,000
+219.9%
23,289
+119.9%
0.00%
Q3 2021$156,00010,5890.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders